Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market: Companies Augment the Availability of Minimally Invasive Treatment
Though the precise etiology is unknown, the striking similarity between benign prostatic hyperplasia (BPH) prostate treatment and the embryonic morphogenesis of the prostate has paved way for the hypothesis that BPH may result from a reawakening in adulthood of embryonic induction processes. The enlarged gland is said to contribute to the lower urinary tract symptoms complex. The restriction of the flow of urine from the bladder tends to cause symptoms such as nocturia, intermittency, urgency, hesitancy and decreased stream. If...
View full press release